![Inès Holzbaur](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Inès Holzbaur
Oprichter bij AmorChem Financial, Inc.
Oorsprong van het eerstegraads netwerk van Inès Holzbaur
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Aegera Therapeutics, Inc.
![]() Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.
11
| Subsidiary | Biotechnology | 11 |
GeneChem Management, Inc.
![]() GeneChem Management, Inc. Investment ManagersFinance GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal.
5
| Private Company | Investment Managers | 5 |
SpecificiT Pharma, Inc.
![]() SpecificiT Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SpecificiT Pharma, Inc. develops personalized cancer immunotherapies. The company is headquartered in Westmount, Canada.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
AgeChem Financial, Inc.
![]() AgeChem Financial, Inc. Financial ConglomeratesFinance AgeChem Financial, Inc. engages in the provision of investment services, It seeks to invest in companies developing therapeutics targeting age-related diseases. The company was founded in 2006 and is headquartered in Montreal, Canada.
3
| Subsidiary | Financial Conglomerates | 3 |
AmorChem Financial, Inc.
![]() AmorChem Financial, Inc. Financial ConglomeratesFinance AmorChem Financial, Inc. provides financial investment services. The company is headquartered in Westmount, Canada.
1
| Subsidiary | Financial Conglomerates | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Inès Holzbaur via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
NORDION INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
GLYCODesign, Inc.
![]() GLYCODesign, Inc. Pharmaceuticals: MajorHealth Technology GLYCODesign, Inc. develops pharmaceutical products. The company engages in the discovery and development of novel therapeutics for life-threatening diseases such as cancer, infectious diseases, inflammation, and cardiovascular diseases. GLYCODesign focuses on inhibiting the enzymes that produce the abnormal carbohydrates. The company was founded by Jeremy Carver in 1993 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Director/Board Member | |
CYPROTEX PLC | Miscellaneous Commercial Services | Director/Board Member | |
AdipoGenix, Inc.
![]() AdipoGenix, Inc. Pharmaceuticals: MajorHealth Technology AdipoGenix, Inc. develops molecular pharmaceutical products. It offers small molecule pharmaceuticals to treat obesity and its co-morbidities. The firm’s technology includes AdipoBASE, AdipoSCREEN, AdipoPATH and AdipoTARGET. The company was founded by Gerri Waloga, Barbara E. Corkey, Stephen R. Farmer, James A. Hamilton, James L. Kirkland, H. Jeff Leighton and Paul F. Pilch in 1997 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
ONCOSEC MEDICAL INCORPORATED | Medical/Nursing Services | Chief Operating Officer | |
Lumira Capital Investment Management, Inc.
![]() Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Investment Managers | Corporate Officer/Principal | |
Hautes Etudes Commerciales | College/University | Graduate Degree | |
BioChem ImmunoSystems, Inc.
![]() BioChem ImmunoSystems, Inc. Pharmaceuticals: MajorHealth Technology BioChem ImmunoSystems, Inc. is an investor group led by management. | Pharmaceuticals: Major | Corporate Officer/Principal | |
McGill University | College/University | Masters Business Admin Graduate Degree Doctorate Degree Undergraduate Degree | |
University of Ottawa | College/University | Doctorate Degree Corporate Officer/Principal | |
University of Toronto | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
University of Montréal | College/University | Graduate Degree | |
PainCeptor Pharma Corp.
![]() PainCeptor Pharma Corp. Pharmaceuticals: MajorHealth Technology PainCeptor Pharma Corp. operates as a biopharmaceutical company which engages in the development of pharmaceuticals for chronic and acute pain. It offers next generation therapeutic drugs for the treatment of chronic and acute pain. The firms products includes NGF/p75-TrkA, ASIC1a and ASIC3. The company was founded by Louis Lamontagne in 2003 and is headquartered in St-Laurent, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Agrisoma Biosciences, Inc.
![]() Agrisoma Biosciences, Inc. Chemicals: SpecialtyProcess Industries Agrisoma Biosciences, Inc. provides crop technology for biofuel and renewable energy solutions. Its crop improvement technologies include proprietary breeding, proprietary tissue culture and haploidy, molecular markers and genetic mapping and advanced crop improvement technologies. The company was founded by Steven Fabijanski and Tom Mamic in 2001 and is headquartered in Gatineau, Canada. | Chemicals: Specialty | Director/Board Member | |
LymphoSign, Inc.
![]() LymphoSign, Inc. BiotechnologyHealth Technology LymphoSign, Inc. develops drugs for the cancer treatment. It also develops drugs acting on signaling pathways involved in the progression of acute leukemias, lymphomas and solid tumors. The company was founded by Chaim Roifman in 2000 and is headquartered in Markham, Canada. | Biotechnology | Director/Board Member | |
Praxim SA
![]() Praxim SA Medical SpecialtiesHealth Technology Praxim SA manufactures and sells orthopedic surgical instruments. It specializes in minimal invasive products for knee arthroscopy. The company was founded by Stéphane Lavallée in 1995 and is headquartered in La Tronche, France. | Medical Specialties | Director/Board Member | |
University of Tasmania | College/University | Doctorate Degree | |
Viron Therapeutics, Inc.
![]() Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Genome Canada
![]() Genome Canada Miscellaneous Commercial ServicesCommercial Services Genome Canada provides genomic research services. It connects ideas and people across public and private sectors to find new uses for genomics, invests in large-scale science and technology to fuel innovation,and translates discoveries into applications, new technologies, societal impacts and solutions across key sectors of national importance, including health, agriculture, forestry, fisheries and aquaculture, energy, mining, and the environment. The company was founded in 2000 and is headquartered in Ottawa, Canada. | Miscellaneous Commercial Services | Chairman | |
Canadian Genetics Diseases Network
![]() Canadian Genetics Diseases Network Miscellaneous Commercial ServicesCommercial Services Canadian Genetics Diseases Network provides research and development services to the healthcare industry. The company is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Alethia Biotherapeutics, Inc.
![]() Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
TraumaTec, Inc.
![]() TraumaTec, Inc. Electronic Equipment/InstrumentsElectronic Technology TraumaTec, Inc. manufactures medical devices. It develops patented, non-invasive, and disposable medical device that specifically targets cooling the brain to mitigate brain injury. The company was founded on March 25, 2003 and is headquartered in Houston, TX. | Electronic Equipment/Instruments | Corporate Officer/Principal | |
Canada Department of National Defence (Canada) | Sovereign | Corporate Officer/Principal | |
Les Équipements Power Survey Ltée
![]() Les Équipements Power Survey Ltée Alternative Power GenerationUtilities Power Survey & Equipment Ltd. provides solutions for measuring and analyzing the intensity of harmonic currents and voltages. Its products include capacitor banks, harmonic filters, accessories and distribution. The firm offers power factor correction, harmonic distortion correction, start-up and commissioning, preventive maintenance, and technical training services for commercial and institutional, industrial and manufacturing, mining, metal and mineral, oil and gas, grid and transportation industries. The company was founded by 1948 and is headquartered in Montreal, Canada. | Alternative Power Generation | Director of Finance/CFO | |
Insitut de Recherche en Immunologie et en Cancérologie
![]() Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Chief Executive Officer | |
DalCor Pharmaceuticals Canada, Inc.
![]() DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
ARTMS, Inc.
![]() ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada. | Biotechnology | Founder | |
Group JS International Ltd. | Director of Finance/CFO | ||
Corbin Therapeutics, Inc.
![]() Corbin Therapeutics, Inc. Internet Software/ServicesTechnology Services Corbin Therapeutics, Inc. operates as a biotechnology platform. | Internet Software/Services | Director/Board Member | |
Thryv Therapeutics, Inc.
![]() Thryv Therapeutics, Inc. Medical/Nursing ServicesHealth Services LQT Therapeutics, Inc. engages in the development of therapies for the treatment of all forms of Long QT Syndrome. The company was founded by Anthony Rosenzweig, Saumya Das and David Milan and is headquartered in Laval, Canada. | Medical/Nursing Services | Director/Board Member | |
Centre For Commercialization of Cancer Immunotherapy
![]() Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. | Chairman Founder | ||
Giiant Pharma, Inc.
![]() Giiant Pharma, Inc. BiotechnologyHealth Technology Giiant Pharma, Inc. is a Canadian preclinical-stage biotech company that specializes in designing gut-restricted small molecule drug therapeutics with various biological targets in gastroenterology. The company is based in Montréal, Canada and was founded by Elizabeth Elizabeth Kwong. The company's proprietary precision delivery technology platform allows for the creation of tissue-specific drugs with improved tolerability and enhanced therapeutic effects. Giiant's first lead program, GT-2108, is a microbiota-activated PDE4 inhibitor prodrug. Maxime Ranger has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
SATELLOS BIOSCIENCE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Epitopea Ltd.
![]() Epitopea Ltd. Miscellaneous Commercial ServicesCommercial Services Epitopea Ltd. is a British transatlantic biotechnology company that develops immunotherapies to treat cancer by targeting a new class of antigens that are broadly shared between patients with the same cancer indication. The company is based in Cambridge, UK. The company has an extensive proprietary library of cryptigen™ tsas that will drive the development of transformational off the shelf cancer immunotherapies. Epitopea was founded in 2021 by Jonathan David Moore, Claude Perreault, and Pierre Thibault. Jonathan David Moore has been the CEO since 2021. | Miscellaneous Commercial Services | Founder Founder | |
Ottawa Life Sciences Council | Director/Board Member |
Statistieken
Internationaal
Canada | 39 |
Verenigde Staten | 8 |
Verenigd Koninkrijk | 3 |
België | 2 |
Frankrijk | 2 |
Sectoraal
Health Technology | 23 |
Commercial Services | 9 |
Consumer Services | 7 |
Finance | 4 |
Health Services | 3 |
Operationeel
Director/Board Member | 79 |
Corporate Officer/Principal | 28 |
Founder | 11 |
Private Equity Investor | 11 |
Undergraduate Degree | 8 |
Sterkste connecties
Insiders | |
---|---|
Louis P. Lacasse | 26 |
Joe Regan | 17 |
Michael B. Cross | 15 |
Giovanni A. Ferrara | 15 |
Perry B. Molinoff | 12 |
Lennie Ryer | 12 |
John W. Gillard | 12 |
Elizabeth Douville | 11 |
Martial Lacroix | 11 |
Serge Langford | 8 |
Nicola Urbani | 6 |
Trudie Resch | 2 |
Claude Perreault | 2 |
Denis Roy | 2 |
Pierre Thibault | 2 |
- Beurs
- Insiders
- Inès Holzbaur
- Bedrijfsconnecties